Your Notifications
All done, no notifications

What is Hodgkin lymphoma (HL)?

Hodgkin lymphoma is a lymphatic malignancy. The lymphatic system is part of the body's immune system, which fights germs and diseases. Hodgkin lymphoma develops when healthy cells in the lymphatic system mutate and expand out of control.

The lymphatic system contains lymph nodes. They are located throughout the body. Most lymph nodes are in the abdomen, groin, pelvis, chest, underarms, and neck.

The lymphatic system contains the spleen, thymus, tonsils, and bone marrow. Hodgkin lymphoma can affect all these locations and other organs in the body.

Hodgkin lymphoma, formerly known as Hodgkin disease, is one of two primary forms of lymphomas. The other is non-Hodgkin's lymphoma.

What is the Importance of Timely Treatment?

  • Timely treatment of Hodgkin Lymphoma (HL) is essential for improving outcomes and increasing the likelihood of a cure. Early detection and action considerably boost the possibility of complete remission, as HL responds favourably to early-stage treatments such as chemotherapy and radiation.
  • Delaying treatment can allow cancer to spread, resulting in serious problems such as organ damage and an increased chance of subsequent cancers. As a result, beginning treatment early increases survival chances and reduces long-term health risks.

What are the Common Symptoms of Hodgkin lymphoma (HL)?

The most frequent initial symptom of Hodgkin lymphoma is painless enlarged lymph nodes in the neck, underarm, or groin. Additional symptoms include:

  • Persistent fatigue: This refers to feeling substantially more fatigued than usual for numerous days.
  • Unexplained fever: A high temperature that persists for two or more hours after home therapy or lasts more than two days may indicate a dangerous condition.
  • Drenching night sweats: Occurrence of excessive sweating
  • Unexplained weight loss: This refers to losing body weight without trying. Losing 10% or more of your body weight in six months indicates unexplained weight loss.
  • Itchy skin (pruritis): Some persons with Hodgkin lymphoma experience extremely itchy skin
  • Abdominal discomfort or edema: Not every abdominal pain indicates a serious illness. Contact a healthcare specialist if you are experiencing significant discomfort that is not going away.
  • Chest discomfort: It could be a symptom of Hodgkin lymphoma in your lung tissues or lymph nodes within your chest.
  • Shortness of breath: This could indicate Hodgkin lymphoma in your lungs or a massive lump in your chest.

Types of Hodgkin Lymphoma

There are four classical Hodgkin lymphoma subtypes:

  • Nodular Sclerosis Hodgkin lymphoma: This is the most prevalent classical Hodgkin lymphoma subtype. It frequently affects young adults. It often affects lymph nodes in the centre of the chest.
  • Mixed cellularity Hodgkin lymphoma: This subtype primarily affects persons in their sixties. It can sometimes develop in your abdomen.
  • Lymphocyte-rich, classic Hodgkin lymphoma: This subtype affects around 6% of all Hodgkin lymphoma patients.
  • Lymphocyte-depleted Hodgkin lymphoma: This subtype affects around 1% of Hodgkin lymphoma patients. It is particularly common among those over the age of 60 and those living with HIV/AIDS.

Stages of Hodgkin Lymphoma

Disease staging assists healthcare providers in determining how advanced the disease is, how quickly it may spread, and which treatments may be most effective. Here are the phases of Hodgkin lymphoma.

  • Stage I: Cancer cells are present in a single lymph node or lymphoid organ. Alternatively, lymphoma can develop in a specific location of an organ other than your lymph system.
  • Stage II: Cancer cells are found in two or more groups of lymph nodes on the same side of the diaphragm (additional lymph nodes nearby may also be affected).
  • Stage III: Lymph node sections on both sides of your diaphragm contain lymphoma cells, or cancer cells are found in lymph nodes above your diaphragm and Spleen.
  • Stage IV: There is lymphoma in at least one organ other than your lymph system, such as your liver, lung, or bone marrow.

Causes, Risk Factors and Complications of Hodgkin lymphoma (HL)

Causes

  • Healthcare professionals are unsure what causes Hodgkin lymphoma. It starts with modifications to the DNA of a lymphocyte, a type of disease-fighting blood cell. A cell's DNA includes instructions that teach it what to do.
  • The DNA modifications instruct the cells to grow rapidly and survive when other cells usually die. Hodgkin lymphoma cells attract many healthy immune system cells, safeguarding and assisting them to grow. Extra cells flock into lymph nodes, causing swelling and other symptoms.

Risk Factors

The following factors can raise the risk of Hodgkin lymphoma:

  • Your age: Hodgkin lymphoma is most commonly diagnosed in persons in their 20s and 30s, as well as those over the age of 65.
  • Family history of Hodgkin lymphoma: Having a blood relative with Hodgkin lymphoma enhances one's risk of developing the disease.
  • Being male: Men are somewhat more likely than women to get Hodgkin lymphoma.
  • People who have previously been infected with the Epstein-Barr virus are more likely to develop Hodgkin lymphoma than those who have not. One example is contagious mononucleosis.
  • HIV infection: People with HIV are more likely to develop Hodgkin lymphoma.

Complications

Complications of Hodgkin lymphoma (HL) can include:

  • Infections
  • Infertility
  • Cardiac complications
  • Pulmonary complications
  • Thyroid dysfunction
  • Second cancers
  • Blood abnormalities

Connect with our advisor for a PRIORITY response

Latest Research and Technologies in the Treatment of Hodgkin Lymphoma (HL) in the United Arab Emirates

  • Patients with Hodgkin lymphoma can now get high-dose chemotherapy without having their bone marrow function compromised thanks to a novel method that uses cryopreserved stem cells. After therapy, the preserved cells are reintroduced to produce new, healthy blood cells, enhancing recuperation and lowering problems.
  • Advanced research in the United Arab Emirates has introduced CAR-T cell therapy for resistant or relapsed Hodgkin lymphoma. This immunotherapy offers a promising treatment for challenging cases by reprogramming a patient's T-cells to target and eliminate cancer cells.

Hodgkin Lymphoma (HL) Prevention Tips

Here are some preventative tips for Hodgkin Lymphoma (HL):

  • Avoid Infections: To avoid infections, practice proper cleanliness and limit exposure to the Epstein-Barr virus (EBV).
  • Healthy Lifestyle: A healthy lifestyle includes eating a balanced diet, exercising regularly, and managing stress.
  • Limit Your Tobacco and Alcohol Consumption: Avoid smoking and drinking excessively.
  • Early Detection: Regular check-ups and awareness of uncommon symptoms will help in early diagnosis.

While these strategies may not ensure prevention, they promote general health and early intervention.

Treatment options for Hodgkin lymphoma (HL)

Chemotherapy: This typical Hodgkin lymphoma treatment employs one or more medications to kill or prevent cancer cells from growing. Providers may utilise one or more types of chemotherapies.


Cost Start From USD 800 - USD 6000Explore Options

Radiation therapy: This therapy employs high-powered laser beams to kill cancer cells in afflicted lymph nodes or areas of malignant dissemination. It is frequently used with chemotherapy for early-stage Hodgkin lymphoma treatment.

Immunotherapy: This treatment strengthens your immune system, making it more effective in identifying and eliminating cancer cells. Checkpoint inhibitors are a key immunotherapy treatment for Hodgkin lymphoma.

{immunotherapy}

Targeted therapy: It is the employment of medications or other substances to attack cancer cells. This treatment employs laboratory-created antibodies that are linked to chemotherapeutic medicines. They identify and eliminate cancer cells.


Cost Start From USD 5500 - USD 54000Explore Options

Bone Marrow Transplant: A bone marrow transplant, also known as a bone marrow stem cell transplant, involves introducing healthy bone marrow stem cells into the body. These cells restore damaged cells caused by chemotherapy and other treatments. If Hodgkin's lymphoma reappears or does not respond to conventional therapies, a bone marrow transplant may be a viable alternative.

{bmt-autologous}
  • Complete blood count (CBC): This test detects low blood cell counts, which may indicate lymphoma in your blood or bone marrow.
  • Blood chemical analysis: This test analyses your electrolyte levels and the function of your liver and kidneys. It examines the compounds that your organs and tissues release into your bloodstream, which may indicate tissue damage.
  • Erythrocyte sedimentation rate (ESR): This test evaluates inflammation. Sedimentation rates are high in Hodgkin's lymphoma.
  • Lactate dehydrogenase (LDH) assay: This test detects a protein that cells release when damaged. Lymphoma can occasionally cause a high LDH rate.
  • Tests for viruses: These tests can detect current or prior diseases associated with Hodgkin lymphoma, such as HIV, hepatitis B, and hepatitis C.
  • Imaging tests: Your doctor may offer imaging tests to look for symptoms of lymphoma in other parts of your body. Chest X-rays, CT scans, MRIS, and positron emission tomography (PET) scans are all possible tests.
  • Bone marrow aspiration and biopsy: There are methods for obtaining cells from the bone marrow. The cells are sent for testing. Tests can detect Hodgkin lymphoma cells.

Rehabilitation for Hodgkin Lymphoma (HL) focuses on assisting patients in recovering physically, emotionally, and cognitively during and after therapy. Key rehabilitation options include:

  • Physical rehabilitation involves tailored exercise regimens that help rebuild strength, enhance mobility, and manage exhaustion caused by chemotherapy or radiation.
  • Lymphatic Drainage: In some circumstances, physical therapy approaches can help with swelling or lymphedema.
  • Dietary Management: Eating a well-balanced diet helps to maintain strength, manage medication side effects, and promote general health.
  • Psychosocial support: Therapy or joining a support group can help cancer patients deal with the emotional and mental challenges of their treatment.

MediGence can assist and guide you in selecting the best physician and medical facility for your care.

Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.

Treatment regimens are adapted to the patient's specific cancer stage and location.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Hodgkin lymphoma (HL) in United Arab Emirates

Zulekha Hospital Sharjah: Top Doctors, and Reviews
Zulekha Hospital Sharjah

Sharjah, United Arab Emirates

Zulekha Hospital Sharjah located in Sharjah, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

  • Zulekha Hospital Sharjah is present over a 290,000 square feet area.
  • The hospital stands today with a bed capacity of 185.
  • The hospital also has a Cardiac Catheterization Laboratory and radiology as well as laboratory services.
  • There is an ICU and Neonatal ICUs.
  • There are facilities for Dialysis and advanced technological applications such as Minimal Invasive surgeries.
  • In Zulekha Hospital Sharjah Bariatric procedures, Joint Replacement, Specialised Cancer Care, Cardio Thoracic and Vascular Procedure, Plastic and Reconstructive Procedure are performed.
  • It also specialises in Pediatric Cardiology, Pulmonology and Chest Diseases, etc.
  • Teleconsultation services as well as an international patient care center with related assistance for medical travelers are functioning in Zulekha Sharjah.
Burjeel Medical City: Top Doctors, and Reviews
Burjeel Medical City

Abu Dhabi, United Arab Emirates

The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more. 

Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-

  • Large waiting areas and consultation rooms 
  • Spacious lobbies on each floor 
  • 338 Luxurious Patient Rooms 
  • 70 Ambulatory Rooms
  • Intensive Care Units
  • The Hospital comprises various centers, under Burjeel Cancer Institute- 
  • Breast Center
  • Uro-oncology Center
  • Surface Malignancy Center (HIPC)
  • Head & Oncology Center
  • Medical Oncology & Hematology Center and others
Zulekha Hospital Dubai: Top Doctors, and Reviews
Zulekha Hospital Dubai

Dubai, United Arab Emirates

Zulekha Hospital Dubai located in Dubai, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

  • The bed capacity of Zulekha Hospital Dubai is 140.
  • Diagnostic centers, pharmacies, inpatient and outpatient care are provided at Zulekha Hospital Dubai.
  • This hospital provides the best of healthcare packages
  • Its surgical base is really strong with the hospital having successfully initiated and completed minimally invasive surgeries, joint replacement surgeries, bariatric surgeries, cardiac, and neonatal surgeries.
  • Radiology, laboratory, operating theatres, dialysis section and Cardiac Catheterization Laboratory are all present in Zulekha Hospital Dubai, UAE.

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose the United Arab Emirates for Hodgkin Lymphoma (HL) Treatment?

Here are some of the reasons for choosing the United Arab Emirates:

  • Expert Oncologists: The United Arab Emirates offers highly trained oncologists who specialise in Hodgkin Lymphoma (HL) and are familiar with the most recent treatments and therapies.
  • Advanced Treatment Options: The United Arab Emirates provides advanced therapies such as chemotherapy, immunotherapy, and stem cell transplants, ensuring tailored care.
  • Cost-Effective Care: Treatment in the United Arab Emirates is less expensive than in many Western countries while keeping high medical standards.
  • International Patient Services: United Arab Emirates's hospitals offer seamless treatment to international patients, including bilingual support and specialised services.
  • Accredited Healthcare Facilities: Many UAE hospitals are JCI-accredited, which ensures good medical care and patient safety.

Frequently Asked Questions

Indeed, if detected early, Hodgkin lymphoma is curable and can be cured. Usually, radiation therapy, chemotherapy, or a mix of the two are used as treatments. Particularly for early-stage illnesses, the survival rates in the United Arab Emirates are in line with the global norm.

Usually, radiation therapy, chemotherapy, or a mix of the two are used as treatments. Chemotherapy is the most popular treatment. In more advanced stages or after a recurrence, stem cell transplants may be considered.

According to studies, the 5- and 10-year survival rates for Hodgkin lymphoma in the United Arab Emirates are over 90%. Access to cutting-edge treatment choices, efficient chemotherapy regimens, and early diagnosis all contribute to these results. The nation's state-of-the-art healthcare system largely makes these positive patient outcomes possible.

Non-Hodgkin lymphoma is more prevalent than Hodgkin lymphoma (HL) in the United Arab Emirates. About 20% of the cases were attributed to HL, while the remaining 80% were attributed to NHL, according to a study conducted at a tertiary centre in the United Arab Emirates. This distribution aligns with worldwide patterns, where NHL is more common than HL.

Standard treatment side effects include nausea, hair loss, exhaustion, infections, and organ damage caused by chemotherapy or radiation. Long-term follow-up is required to monitor for any residual effects.

​The majority of patients in the United Arab Emirates who receive treatment for Hodgkin lymphoma experience remission and have excellent long-term results. Early diagnosis, efficient chemotherapy treatments like ABVD, and the availability of cutting-edge imaging and interdisciplinary care are all responsible for this. Research has demonstrated that there have been no deaths or relapses during follow-up, demonstrating the efficacy of current treatment approaches.